Correction to: Transcatheter Annuloplasty for Mitral Regurgitation with an Adjustable Semi-Rigid Complete Ring: Initial Experience with the Millipede IRIS Device (Structural Heart, (2018), 2, 1, (43-50), 10.1080/24748706.2017.1385879);Transcatheter Annuloplasty for Mitral Regurgitation with an Adjustable Semi-Rigid Complete Ring: Initial Experience with the Millipede IRIS Device

Structural Heart

Volumn 2, Issue 1, 2018, Pages 43-50

  Rogers, Jason H ^a   Boyd, Walter D ^b   Smith, Thomas W R ^a   Ebner, Adrian A ^c   Grube, Eberhard ^d   Bolling, Steven F ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Italian Hospital   (Paraguay)

^d UNIVERSITY HOSPITAL BONN   (Germany)

^e UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

mitral annuloplasty; Mitral regurgitation; transcatheter mitral valve repair

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART TAMPONADE; HUMAN; INTRACARDIAC ECHOCARDIOGRAPHY; MALE; MITRAL ANNULOPLASTY; MITRAL VALVE REGURGITATION; NEW YORK HEART ASSOCIATION CLASS; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRANSCATHETER ANNULOPLASTY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID ANNULOPLASTY; TRICUSPID VALVE REGURGITATION; VASCULAR ACCESS;

EID: 85102394186     PISSN: 24748706     EISSN: 24748714     Source Type: Journal    
DOI: 10.1080/24748706.2020.1835343     Document Type: Erratum

References (17)

1. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Eur Heart J. 2003;24(13):1231–1243. doi:10.1016/S0195-668X(03)00201-X.
2. Robbins JD, Maniar PB, Cotts W, Parker MA, Bonow RO, Gheorghiade M., Prevalence and severity of mitral regurgitation in chronic systolic heart failure. Am J Cardiol. 2003;91(3):360–362. doi:10.1016/S0002-9149(02)03172-7.
3. Stone GW, Vahanian AS, Adams DH, et al. Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: Part 1: Clinical trial design principles: a consensus document from the mitral valve academic research consortium. J Am Coll Cardiol. 2015;66(3):278–307. doi:10.1016/j.jacc.2015.05.046.
4. Gillinov AM, Cosgrove DM, Blackstone EH, et al. Durability of mitral valve repair for degenerative disease. J Thorac Cardiovasc Surg. 1998;116(5):734–743. doi:10.1016/S0022-5223(98)00450-4.
5. Spoor MT, Geltz A, Bolling SF. Flexible versus nonflexible mitral valve rings for congestive heart failure: differential durability of repair. Circulation. 2006;114(1 Suppl):I–71. doi:10.1161/CIRCULATIONAHA.105.001453.
6. Timek TA, Lai DT, Tibayan F, et al. Septal-lateral annular cinching abolishes acute ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 2002;123(5):881–888. doi:10.1067/mtc.2002.122296.
7. Nickenig G, Hammerstingl C, Schueler R, et al. Transcatheter mitral annuloplasty in chronic functional mitral regurgitation: 6-month results with the Cardioband Percutaneous Mitral Repair System. JACC Cardiovasc Interv. 2016;9(19):2039–2047. doi:10.1016/j.jcin.2016.07.005.
8. Rogers JH, Thomas M, Morice MC, et al. Treatment of heart failure with associated functional mitral regurgitation using the ARTO system: initial results of the first-in-human MAVERIC Trial (Mitral Valve Repair Clinical Trial). JACC Cardiovasc Interv. 2015;8(8):1095–1104. doi:10.1016/j.jcin.2015.04.012.
9. Nickenig G, Schueler R, Dager A, et al. Treatment of chronic functional mitral valve regurgitation with a percutaneous annuloplasty system. J Am Coll Cardiol. 2016;67(25):2927–2936. doi:10.1016/j.jacc.2016.03.591.
10. Siminiak T, Wu JC, Haude M, et al. Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial. Eur J Heart Fail. 2012;14(8):931–938. doi:10.1093/eurjhf/hfs076.
11. Braun J, Van De Veire NR, Klautz RJ, et al. Restrictive mitral annuloplasty cures ischemic mitral regurgitation and heart failure. Ann Thorac Surg. 2008;85(2):430–437. doi:10.1016/j.athoracsur.2007.08.040.
12. Magne J, Pibarot P, Dagenais F, Hachicha Z, Dumesnil JG, Senechal M. Preoperative posterior leaflet angle accurately predicts outcome after restrictive mitral valve annuloplasty for ischemic mitral regurgitation. Circulation. 2007;115(6):782–791. doi:10.1161/CIRCULATIONAHA.106.649236.
13. Calafiore AM, Gallina S, Di Mauro M, et al. Mitral valve procedure in dilated cardiomyopathy: repair or replacement? Ann Thorac Surg. 2001;71(4):1146–1152; discussion 1152–1143. doi:10.1016/S0003-4975(00)02650-3.
14. Acker MA, Parides MK, Perrault LP, et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med. 2014;370(1):23–32. doi:10.1056/NEJMoa1312808.
15. Kron IL, Hung J, Overbey JR, et al. Predicting recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 2015;149(3):752–761.e1. doi:10.1016/j.jtcvs.2014.10.120.
16. Latib A, Ancona MB, Ferri L, et al. Percutaneous direct annuloplasty with cardioband to treat recurrent mitral regurgitation after mitraclip implantation. JACC Cardiovasc Interv. 2016;9(18):e191–192. doi:10.1016/j.jcin.2016.06.028.
17. Navia JL, Nowicki ER, Blackstone EH, et al. Surgical management of secondary tricuspid valve regurgitation: annulus, commissure, or leaflet procedure? J Thorac Cardiovasc Surg. 2010;139(6):1473–1482.e5. doi:10.1016/j.jtcvs.2010.02.046.